NOVO NORDISK A/S
Nordisk will compete in Tour of Denmark (Post Danmark Rundt). Team Novo Nordisk is a global all-diabetes sports team of cyclists, triathletes and runners, spearheaded by the professional cycling team. Team Novo Nordisk's mission is to educate, empower and inspire people affected by diabetes by showing that even though you have diabetes, you can still achieve your goals.
Since the launch in December 2012, Team Novo Nordisk has competed in more than 81 professional races and achieved more than 39 top ten finishes. The team has more than
700,000 followers on Facebook, making it the most followed cycling team globally on
social media.
"Racing in Tour of Denmark last year was a great experience and we're looking very much forward to coming back to the home country of Novo Nordisk in August," says Phil Southerland, co-founder and CEO of Team Novo Nordisk. "When you are diagnosed with a chronic disease like diabetes, you might need to be reminded that it is still possible to live life the way you wish. The riders in Team Novo Nordisk are living proof that it is possible to live your dreams and that you should not see your disease as a limiting factor."
When the final stage of the Tour of Denmark race is kicked off on 10 August, the peloton will ride through Novo Nordisk's production site in Kalundborg, where half of the world's insulin is produced.
Team Novo Nordisk will participate with the following eight riders in Tour of Denmark
2014: Andrea Peron (Italy), Martijn Verschoor (Netherlands), Chris Williams (Australia), Nicolas Lefrancois (France), Kevin DeMesmaeker (Belgium), Paolo Cravanzola (Italy),
Scott Ambrose (New Zealand) and Stephen Clancy (Ireland).
Corporate Communications
Novo Allé
2880 Bagsværd
Denmark
Telephone:
+45 4444 8888
HQMMA/CD/0614/0051
Date of Approval: June 2014
Internet: www.novonordisk.com CVR no:
24 25 67 90
Page 2 of 2
About diabetesToday, 382 million people are living with diabetes1, and data from the Danish Diabetes Association show that more than 320,000 people in Denmark have diabetes. In addition, it is estimated that 200,000 have type 2 diabetes without knowing it and 750,000 Danes have prediabetes2. Team Novo Nordisk is part of Changing Diabetes®, Novo Nordisk's global commitment to improve conditions for the millions of people living with diabetes today, and those at risk of developing diabetes tomorrow.
About Tour of Denmark
Tour of Denmark (Post Danmark Rundt) is categorised by the Union Cycliste Internationale (UCI) as a 2.HC race. It is an annual event of approximately 800 kilometres, and in 2014 the race celebrates its 24th anniversary. Again this year Novo Nordisk is sponsoring the Changing Diabetes® points jersey. Classifications, results and other information about the race will be published at www.teamnovonordisk.com, and it is also possible to follow the team at www.facebook.com/TeamNovoNordiskand
www.twitter.com/TeamNovoNordisk.
Headquartered in Denmark, Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. Novo Nordisk employs approximately
40,000 employees in 75 countries, and markets its products in more than 180 countries. For more information, visit novonordisk.com.
Further informationLars Pallisgaard +45 3079 3730 lplg@novonordisk.com
References1 International Diabetes Federation. IDF Diabetes Atlas, 6th Edition, 2013 Update. Brussels, Belgium: International Diabetes Federation. Available from: www.idf.org/diabetesatlas. Latest access: November 2013
2 The Danish Diabetes Association, Diabetes i Danmark. Available from:
http://www.diabetes.dk/presse/diabetes-i-tal/diabetes-i-danmark.aspx. Latest access: June
2014
Novo Nordisk A/SCorporate Communications
Novo Allé
2880 Bagsværd
Denmark
Telephone:
+45 4444 8888
HQMMA/CD/0614/0051
Date of Approval: June 2014
Internet: www.novonordisk.com CVR no:
24 25 67 90
|
distributed by
|
